201 related articles for article (PubMed ID: 25802082)
1. Pharmacologic inhibition of 5-lipoxygenase improves memory, rescues synaptic dysfunction, and ameliorates tau pathology in a transgenic model of tauopathy.
Giannopoulos PF; Chu J; Sperow M; Li JG; Yu WH; Kirby LG; Abood M; Praticò D
Biol Psychiatry; 2015 Nov; 78(10):693-701. PubMed ID: 25802082
[TBL] [Abstract][Full Text] [Related]
2. The direct role of 5-lipoxygenase on tau pathology, synaptic integrity and cognition in a mouse model of tauopathy.
Vagnozzi AN; Giannopoulos PF; Praticò D
Transl Psychiatry; 2017 Dec; 7(12):1288. PubMed ID: 29249809
[TBL] [Abstract][Full Text] [Related]
3. Zileuton improves memory deficits, amyloid and tau pathology in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Li JG; Praticò D
PLoS One; 2013; 8(8):e70991. PubMed ID: 23951061
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of 5-Lipoxygenase Worsens the Phenotype of a Mouse Model of Tauopathy.
Giannopoulos PF; Praticò D
Mol Neurobiol; 2018 Jul; 55(7):5926-5936. PubMed ID: 29128902
[TBL] [Abstract][Full Text] [Related]
5. Brain 5-lipoxygenase over-expression worsens memory, synaptic integrity, and tau pathology in the P301S mice.
Vagnozzi AN; Giannopoulos PF; Praticò D
Aging Cell; 2018 Feb; 17(1):. PubMed ID: 29106033
[TBL] [Abstract][Full Text] [Related]
6. Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease.
Giannopoulos PF; Chu J; Joshi YB; Sperow M; Li JG; Kirby LG; Praticò D
Mol Psychiatry; 2014 Apr; 19(4):511-8. PubMed ID: 23478745
[TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase pharmacological blockade decreases tau phosphorylation in vivo: involvement of the cyclin-dependent kinase-5.
Chu J; Praticò D
Neurobiol Aging; 2013 Jun; 34(6):1549-54. PubMed ID: 23332172
[TBL] [Abstract][Full Text] [Related]
8. Learning Impairments, Memory Deficits, and Neuropathology in Aged Tau Transgenic Mice Are Dependent on Leukotrienes Biosynthesis: Role of the cdk5 Kinase Pathway.
Giannopoulos PF; Chiu J; Praticò D
Mol Neurobiol; 2019 Feb; 56(2):1211-1220. PubMed ID: 29881943
[TBL] [Abstract][Full Text] [Related]
9. Zileuton restores memory impairments and reverses amyloid and tau pathology in aged Alzheimer's disease mice.
Di Meco A; Lauretti E; Vagnozzi AN; Praticò D
Neurobiol Aging; 2014 Nov; 35(11):2458-2464. PubMed ID: 24973121
[TBL] [Abstract][Full Text] [Related]
10. Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice.
Giannopoulos PF; Chiu J; Praticò D
Aging Cell; 2018 Jun; 17(3):e12759. PubMed ID: 29607621
[TBL] [Abstract][Full Text] [Related]
11. Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
Lauretti E; Li JG; Di Meco A; Praticò D
Transl Psychiatry; 2017 Jan; 7(1):e1020. PubMed ID: 28140402
[TBL] [Abstract][Full Text] [Related]
12. 12/15-Lipoxygenase Inhibition Reverses Cognitive Impairment, Brain Amyloidosis, and Tau Pathology by Stimulating Autophagy in Aged Triple Transgenic Mice.
Di Meco A; Li JG; Blass BE; Abou-Gharbia M; Lauretti E; Praticò D
Biol Psychiatry; 2017 Jan; 81(2):92-100. PubMed ID: 27499089
[TBL] [Abstract][Full Text] [Related]
13. Knockout of 5-lipoxygenase prevents dexamethasone-induced tau pathology in 3xTg mice.
Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Aug; 12(4):706-11. PubMed ID: 23634895
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of brain homocysteine directly modulate the pathological phenotype of a mouse model of tauopathy.
Di Meco A; Li JG; Barrero C; Merali S; Praticò D
Mol Psychiatry; 2019 Nov; 24(11):1696-1706. PubMed ID: 29728702
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of p25/Cdk5 Attenuates Tauopathy in Mouse and iPSC Models of Frontotemporal Dementia.
Seo J; Kritskiy O; Watson LA; Barker SJ; Dey D; Raja WK; Lin YT; Ko T; Cho S; Penney J; Silva MC; Sheridan SD; Lucente D; Gusella JF; Dickerson BC; Haggarty SJ; Tsai LH
J Neurosci; 2017 Oct; 37(41):9917-9924. PubMed ID: 28912154
[TBL] [Abstract][Full Text] [Related]
16. Minocycline and St. John's wort as therapeutic drugs for human tauopathy.
Hashimoto K
Biol Psychiatry; 2015 Nov; 78(10):e39. PubMed ID: 26412443
[No Abstract] [Full Text] [Related]
17. The 12-15-lipoxygenase is a modulator of Alzheimer's-related tau pathology in vivo.
Giannopoulos PF; Joshi YB; Chu J; Praticò D
Aging Cell; 2013 Dec; 12(6):1082-90. PubMed ID: 23862663
[TBL] [Abstract][Full Text] [Related]
18. The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy.
Hansen HH; Barkholt P; Fabricius K; Jelsing J; Terwel D; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Mar; 1634():158-170. PubMed ID: 26746341
[TBL] [Abstract][Full Text] [Related]
19. The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence.
Chu J; Li JG; Ceballos-Diaz C; Golde T; Praticò D
Biol Psychiatry; 2013 Sep; 74(5):321-8. PubMed ID: 23352590
[TBL] [Abstract][Full Text] [Related]
20. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
